RID PUTS SPOTLIGHT ON INNOVATIVE INFECTION-FIGHTING TECHNOLOGIES
New Innovative Products Spotlight will showcase latest weapons in the war against HAIs
The Committee to Reduce Infection Deaths (RID) is looking for the newest disinfecting and germ-killing technologies as part of its ongoing mission to combat the scourge of deadly hospital infections.
RID knows technological innovation is key, along with rigorous cleaning and an institution-wide commitment to patient safety.
Today, RID is launching its Innovative Products Spotlight, a website bulletin that will bring attention to the newest, cutting-edge technologies. RID’s Innovative Products Spotlight will help medical practitioners, hospitals and medical facilities, as well as the general public, stay abreast of the latest technological advances and developments in this rapidly evolving field.
To notify RID about your innovative product or technology, please contact: email@example.com/ridv1
Each year, hospital infections kill at least 75,000 people — double the toll from car accidents and over 10 times the toll from HIV/AIDS. These deadly superbugs include Carbapenem-resistant bacteria, or CRE, as well as a germ called C. diff, which kills 29,000 people in America each year. More recently, medical practitioners are grappling with another deadly threat called Candida Auris.
The Innovative Products Spotlight will play a critical role in bringing new infection preventing weapons to the forefront.
CRITERIA FOR CONSIDERATION
To submit your product or innovation for consideration, please provide information in a text-based document, limited to 2-3 pages, on the following points:
– Name of product or innovation
– Intended audience or market for this product. Is it currently in use in any medical or healthcare facilities? If so, where? If not, how close is it to reaching the market?
– Infection(s) it is intended to address, including information on the scale of the problem or estimated number of people affected each year
– Brief explanation of how the product works, including status of regulatory approvals and/or patent status
– How effective is the product? Have there been clinical trials? Any peer-reviewed published literature regarding efficacy?
– Additional relevant information you wish to include
To notify RID about your innovative product or technology, or if you have additional questions, please contact: firstname.lastname@example.org/ridv1